S&P Healthcare 18,500.00 10.11%
  • Sun Pharmaceutical Industries Ltd. 0000.00
  • Divi’s Laboratories Ltd. 0000.00
  • Cipla Ltd. 0000.00
  • Torrent Pharmaceuticals Ltd. 0000.00
  • Dr. Reddy’s Laboratories Ltd. 0000.00
  • Zydus Lifesciences Ltd. 0000.00
  • Mankind Pharma Ltd. 0000.00
  • Lupin Ltd. 0000.00
  • Aurobindo Pharma Ltd. 0000.00
  • Alkem Laboratories Ltd. 0000.00
  • Glenmark Pharmaceuticals Ltd. 0000.00
  • Natco Pharma Ltd. 0000.00
  • Shilpa Medicare Ltd. 0000.00
  • Ajanta Pharma Ltd. 0000.00
  • J B Chemicals & Pharmaceuticals Ltd. 0000.00
  • Apollo Hospitals Enterprise Ltd. 0000.00
  • Fortis Healthcare Ltd. 0000.00
  • Max Healthcare Institute Ltd. 0000.00
  • Narayana Hrudayalaya Ltd. 0000.00
  • Shalby Ltd. 0000.00
  • Poly Medicure Ltd. 0000.00
  • Medi Assist India Ltd. 0000.00
  • ICICI Lombard General Insurance Company Ltd. 0000.00
  • HDFC Life Insurance Company Ltd. 0000.00
  • SBI Life Insurance Company Ltd. 0000.00
  • Bajaj Finserv Ltd. 0000.00
  • Metropolis Healthcare Ltd. 0000.00
  • Thyrocare Technologies Ltd. 0000.00

Digital Innovation is Reshaping Clinical Research in India, Says ISCR President Seema Pai

Digital Innovation is Reshaping Clinical Research in India, Says ISCR President Seema Pai

The event brought together more than 1,900 participants and over 285 speakers and clinical researchers

The Indian Society for Clinical Research (ISCR) recently concluded its 19th Annual Conference in New Delhi, highlighting the developments in digital innovation, regulatory processes, and global collaboration in clinical research.

The conference was based on the theme “Accelerating Clinical Research in India through Digital Innovation, Global Collaboration and Regulatory Excellence for Patient-Centric Value Creation” and featured pre-conference workshops on February 12, followed by the two-day main conference on February 13 & 14, 2026.

The event brought together more than 1,900 participants and over 285 speakers and clinical researchers and saw participation of representatives across Indian and global pharmaceutical and medical diagnostics companies, research and development professionals, trainees, and startups.

The discussions centered around the emerging trends, evolving regulatory frameworks, and the growing role of digital technologies in clinical research.

The sessions highlighted the global clinical development pathways, strengthening operational standards at clinical trial sites, regulatory efficiencies and harmonization, global collaboration, data integrity, innovation, and patient-centric research models.

Further, the participants also examined how digital tools and collaborative frameworks are influencing clinical trial design and execution in India.

Highlighting the significance of clinical research, President of ISCR, Dr. Seema Pai, said, “India’s clinical research ecosystem is undergoing a significant shift driven by rapid advances in digital technologies, data-led research models, and a growing focus on patient-centric trial design. Together, these developments are enabling more efficiency, inclusiveness, and scalable clinical research, while also strengthening patient engagement and trust across the research lifecycle.”

She also added, “Recent regulatory reforms and policy measures, including continued emphasis on healthcare, innovation, and research in the Union Budget, reflect India’s strong commitment to building a globally aligned and future-ready clinical research environment."

The conference concluded with participants emphasizing collaboration among stakeholders to translate discussions into action and to support the continued development of patient-focused, technology-enabled clinical research in India.

Stay tuned for more such updates on Digital Health News

Follow us

More Articles By This Author


Show All